Printer Friendly

Belgium : NEW MEDICAL information tool is being launched by Janssen.

Janssen Scientific Affairs debuted a new online scientific resource for U.S. healthcare professionals looking for instant access to current information about Janssen products marketed in the United States.

AWeb-based application, JanssenMD is intended for use on desktops, tablets and smartphones, has search functionality that enables clinicians to easily find full prescribing information, clinical trial data and safety information about Janssen medications.

Company stated that, at present scientific information is available for five pharmaceutical products: Edurant (rilpivirine), Remicade (infliximab), Stelara (ustekinumab), Xarelto (rivaroxaban) and Zytiga (abiraterone acetate).

"JanssenMD was created to provide healthcare professionals with the information they need, when, where, and how they need it," "This unique digital platform enables us to respond to healthcare professionals' questions with information that is current, accurate, and instantly accessible from any device they are using," said by Norm Rosenthal, chief scientific officer at Janssen Scientific Affairs.

2012 Al Bawaba (

Provided by an company
COPYRIGHT 2012 Al Bawaba (Middle East) Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Mena Report
Date:Sep 28, 2012
Previous Article:Belgium : Barco achieves DCI certification for CineStore SoloG3 digital cinema server.
Next Article:Belgium : Belgacom and KPN Group Belgium signed an agreement to supply VDSL2 technology.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters